Biopharma

Sanofi snags GSK’s Chris Corsico to serve as global head of development

Sanofi snags GSK’s Chris Corsico to serve as global hea...

Mar 31, 2025 0

Christopher Corsico, M.D., has left GSK to become Sanofi’s global head of develo...

STAT+: More HHS cuts, and DOJ seeks to recoup loans from Medicaid fraudster

STAT+: More HHS cuts, and DOJ seeks to recoup loans fro...

Mar 31, 2025 0

DOJ takes a new approach on Medicaid fraud, a revamped lawsuit against UnitedHea...

Lung Cancer Screening Rates Increased After 2021 Update to USPSTF Guidelines

Lung Cancer Screening Rates Increased After 2021 Update...

Mar 31, 2025 0

MONDAY, March 31, 2025 -- Increased lung cancer screening uptake was seen after...

Persistently High Stroke Risk Seen After TIA, Minor Stroke

Persistently High Stroke Risk Seen After TIA, Minor Stroke

Mar 31, 2025 0

MONDAY, March 31, 2025 -- The risk for subsequent stroke is persistently high f...

Low Creatinine-to-Cystatin C Ratio Tied to Lower Muscle Volume in Midlife Women

Low Creatinine-to-Cystatin C Ratio Tied to Lower Muscle...

Mar 31, 2025 0

MONDAY, March 31, 2025 -- Among middle-aged women, low creatinine-to-cystatin C...

Speed of Resuscitation Critical to Survival Outcomes After Cardiac Arrest Events

Speed of Resuscitation Critical to Survival Outcomes Af...

Mar 31, 2025 0

MONDAY, March 31, 2025 -- For patients with out-of-hospital cardiac arrest (OHC...

Evidence Supports Continuing Buprenorphine for Acute Pain in Those With Opioid Use Disorder

Evidence Supports Continuing Buprenorphine for Acute Pa...

Mar 31, 2025 0

MONDAY, March 31, 2025 -- For patients with opioid use disorder (OUD), evidence...

Guideline Adherence Suboptimal for Chlamydia, Gonorrhea Treatment

Guideline Adherence Suboptimal for Chlamydia, Gonorrhea...

Mar 31, 2025 0

MONDAY, March 31, 2025 -- Across primary care practices, guideline adherence re...

AstraZeneca bulks up Imfinzi's prowess with FDA nod in bladder cancer around surgery

AstraZeneca bulks up Imfinzi's prowess with FDA nod in ...

Mar 31, 2025 0

Imfinzi is the first immunotherapy cleared in the U.S. to treat muscle-invasive ...

FDA official’s ouster sends shares of vaccine makers sliding

FDA official’s ouster sends shares of vaccine makers sl...

Mar 31, 2025 0

Shares in Moderna, Vaxcyte, Novavax and BioNTech all fell Monday after Peter Mar...

AstraZeneca's oral PCSK9 inhibitor halves cholesterol in phase 2 trial

AstraZeneca's oral PCSK9 inhibitor halves cholesterol i...

Mar 31, 2025 0

AstraZeneca’s small molecule halved levels of a type of “bad” cholesterol after ...

Lilly study data reinforce potential of new kind of heart drug

Lilly study data reinforce potential of new kind of hea...

Mar 31, 2025 0

Drugs from Novartis, Amgen and now Lilly have proven powerfully effective at red...

Fierce Biotech Fundraising Tracker '25: Isomorphic hauls in $600M; Epicrispr claims $68M series B

Fierce Biotech Fundraising Tracker '25: Isomorphic haul...

Mar 31, 2025 0

The Fierce Biotech Fundraising Tracker records venture capital rounds of $50 mil...

FDA reviews Novo Nordisk's bid to expand Rybelsus as oral GLP-1 cuts heart disease risks

FDA reviews Novo Nordisk's bid to expand Rybelsus as or...

Mar 31, 2025 0

The FDA has accepted Novo Nordisk's application for a label expansion for oral G...

Judge levies $1.64B penalty on Johnson & Johnson in HIV drug marketing case

Judge levies $1.64B penalty on Johnson & Johnson in HIV...

Mar 31, 2025 0

Nearly a year after a jury decided that Johnson & Johnson should be fined just o...

Human medicines European public assessment report (EPAR): Giotrif, afatinib, Date of authorisation: 25/09/2013, Revision: 17, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 31, 2025 0

Human medicines European public assessment report (EPAR): Giotrif, afatinib, Dat...

Corcept's investigational oral therapy cuts ovarian cancer progression by 30%, teeing up FDA filing

Corcept's investigational oral therapy cuts ovarian can...

Mar 31, 2025 0

Corcept Therapeutics’ oral antiglucocorticoid plus chemotherapy slashed risk of ...

As FDA's Peter Marks resigns, industry watchers size up vaccine, cell and gene therapy hits

As FDA's Peter Marks resigns, industry watchers size up...

Mar 31, 2025 0

In resigning as director of the FDA’s Center for Biologics Evaluation and Resear...

GE HealthCare unveils cardiac-focused CT scanner, launches coronary radiotracer

GE HealthCare unveils cardiac-focused CT scanner, launc...

Mar 31, 2025 0

The Revolution Vibe scanner includes what the company describes as unlimited one...

Human medicines European public assessment report (EPAR): Locametz, gozetotide, Date of authorisation: 09/12/2022, Revision: 7, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 31, 2025 0

Human medicines European public assessment report (EPAR): Locametz, gozetotide, ...

As FDA's Peter Marks resigns, industry watchers eye vaccine, cell and gene therapy hits

As FDA's Peter Marks resigns, industry watchers eye vac...

Mar 31, 2025 0

In resigning as director of the FDA’s Center for Biologics Evaluation and Resear...

Human medicines European public assessment report (EPAR): Zebinix, eslicarbazepine acetate, Date of authorisation: 21/04/2009, Revision: 32, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 31, 2025 0

Human medicines European public assessment report (EPAR): Zebinix, eslicarbazepi...

Google DeepMind’s drug discovery spin-off Isomorphic Labs raises $600mn

Google DeepMind’s drug discovery spin-off Isomorphic La...

Mar 31, 2025 0

AI unit is boosted by first external funding round led by OpenAI-backer Thrive C...

Corcept’s investigational oral therapy cuts ovarian cancer progression by 30%, teeing up FDA filing

Corcept’s investigational oral therapy cuts ovarian can...

Mar 31, 2025 0

Corcept Therapeutics’ oral antiglucocorticoid plus chemotherapy slashed risk of ...

50
51
52
53
54

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.